- $6.82m
- $5.14m
- $29.21m
Brief: Xpresspa Group Announces Strategic Acquisition Of Hyperpointe
Brief: Xpresspa Group Reports Preliminary Q4, Full Year 2021 Revenue
Brief: Ginkgo Bioworks Holdings Says It Has Identified, Sequenced Three Samples Containing Omicron Variant
U.S. CDC urges Americans to avoid travel to Niger, Poland over COVID-19 (updated)
Brief: Xpresspa Group And Ginkgo Bioworks Collaboration With CDC Covid-19 Biosurveillance Program Expands To Include Detection Of New Omicron Variant
XpresSpa Group Inc reports results for the quarter ended in September - Earnings Summary
Brief: XpresSpa Group Reports Q3 2021 Results
XpresSpa Group Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Xprescheck To Open COVID-19 Testing Facility At Hartsfield-Jackson Atlanta International Airport
XpresSpa Group rises on plans to repurchase 15 million shares
Brief: XpresSpa Authorizes Stock Repurchase Program
XpresSpa Group Inc reports results for the quarter ended in June - Earnings Summary
Brief: XpresSpa Group Q2 Revenue $9.1 Million
XpresSpa Group Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: XpresSpa Group Receives Approval For For Biosurveillance Tracking In Collaboration With Concentric By Ginkgo At Three Major U.S. Airports
Brief: Xpresspa Group Announces New Pilot Program In Collaboration With EL AL Israel Airlines
Brief: XpresSpa Group Announces The Re-Opening Of XpresSpa Locations By July 1
Brief: Xpresspa Group Set To Join Russell Microcap® Index
XpresSpa Group Inc reports results for the quarter ended in March - Earnings Summary